TruScreen (ASX:TRU): Interview with CEO Juliet Hull

June 8, 2021

TRU, Truscreen

Summary

We spoke with TruScreen Group (ASX:TRU) CEO Juliet Hull from New Zealand about the opportunity of the TruScreen technology in emerging markets to provide a lower cost and more patient friendly alternative for cervical cancer diagnosis. In particular we talked about the Chinese market, which is expected to be a significant value driver.

 

Stocks Down Under … Must-have information for the serious investor!

 

Get Marc & Stuart’s Top Picks

Improve your investment skills with our Investor Webinars

Learn about ASX-listed stocks with our 4 editions per week across all sectors

 

Get access to everything with a 30-day FREE TRIAL.

No credit card required!

GET A 30-DAY FREE TRIAL